WHO ICTRP trial
Evaluation of preventive efficacy of valaciclovir hydrochloride in herpes…
EUCTR2015-004869-88-Outside-EU/EEA · EU Clinical Trials Register
Key facts
| Trial ID | EUCTR2015-004869-88-Outside-EU/EEA |
|---|---|
| Public title | Evaluation of preventive efficacy of valaciclovir hydrochloride in herpes simplex virus infection for hematopoietic stem cell transplantation patients. |
| Scientific title | A multicenter, open-label study to evaluate preventive efficacy for herpes simplex virus infection and safety of 256U87 (valaciclovir hydrochloride) in adult and pediatric hematopoietic stem cell transplantation patients. |
| Primary sponsor | GlaxoSmithKline K.K. (GSK) |
| Registry | EU Clinical Trials Register |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Japan |
| Conditions | Herpes simplex virus (HSV) infection before and after hematopoietic stem cell transplantation.;Therapeutic area: Diseases [C] - Virus Diseases [C02] |
| Interventions | Trade Name: Valtrex Pharmaceutical Form: Film-coated tablet INN or Proposed INN: VALACICLOVIR HYDROCHLORIDE Other descriptive name: VALACICLOVIR HYDROCHLORIDE Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Dec 21, 2016 |
| Target size | 40 |
| Secondary IDs | HS2116100 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: